Detalhe da pesquisa
1.
In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs.
Cancer Cell Int
; 23(1): 275, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978493
2.
The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk.
BMC Med
; 20(1): 255, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35978404
3.
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.
J Transl Med
; 17(1): 307, 2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500625
4.
A serum metabolic biomarker panel for early rheumatoid arthritis.
Front Immunol
; 14: 1253913, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720214
5.
Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro.
Cancers (Basel)
; 13(18)2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572917
6.
A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis.
Front Immunol
; 12: 790880, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868079
7.
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness.
Cancers (Basel)
; 13(2)2021 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440913
8.
Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNFα-Induced Insulin Resistance.
J Clin Endocrinol Metab
; 103(4): 1447-1458, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409019